Atrial fibrillation and thrombophilia. DOAC as a valid alternative? A clinical case

Abstract

Oral anticoagulation is a milestone in the management of atrial fibrillation (AF). In complex settings, involving some kinds of thrombophilia, a condition predisposing to higher risk of thromboembolism, warfarin can be ineffective. Direct oral anticoagulants (DOACs) demonstrated to be a valid therapeutic option; in particular edoxaban proved to be effective and safe. We show the case of a man with AF and thrombophilia who developed a thrombus in the left atrial appendage (LAA) despite anticoagulant therapy with warfarin, subsequently treated with edoxaban.